Einträge von Wassmann, B. auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Gehe zu: Artikel
Anzahl der Einträge: 2.
Artikel
Pfeifer, Heike, Goekbuget, Nicola, Völp, Christian, Hüttmann, Andreas, Lübbert, Michael, Stuhlmann, Reingard, Dengler, Julanta, Kreuzer, Karl-Anton, Beck, Joachim, Stelljes, Matthias, Schmid, Mathias, Wassmann, B., Leimer, Lothar, Spiekermann, Karsten, Terwey, Theis H, Schäfer-Eckart, K., Ditz, D., Lindemann, H., Morgner, A., Schaich, Markus, Burmeister, Thomas, Binckebanck, A., Hoelzer, Dieter und Ottmann, Oliver G.
(2010)
Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).
Blood 116 (21), S. 173.
Volltext nicht vorhanden.
(2010)
Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).
Blood 116 (21), S. 173.
Volltext nicht vorhanden.
Wassmann, B., make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(2006)
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).
Blood 108 (5), S. 1469-1477.
Volltext nicht vorhanden.
(2006)
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).
Blood 108 (5), S. 1469-1477.
Volltext nicht vorhanden.
